Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Osiris Therapeutics, Inc. v. MiMedx Group, Inc.
Case Number:
1:18-cv-00950
Court:
Nature of Suit:
Judge:
Companies
Sectors & Industries:
-
December 13, 2018
MiMedx Dodges Rival's $6.8M Trade Secret, Breach Suit
A Maryland federal judge has tossed claims brought by regenerative medicine company Osiris Therapeutics Inc. that its rival MiMedx Group Inc. breached a contract and stole trade secrets when the company acquired Osiris' former distributor, holding that the court lacked jurisdiction to hear the lawsuit.
-
April 03, 2018
Rival Hits MiMedx With $6.8M Breach, Trade Secrets Suit
Regenerative medicine company MiMedx Group Inc. used its acquisition of a distributor to steal clients and withhold commissions from rival Osiris Therapeutics Inc., according to a $6.8 million suit filed in Maryland federal court Monday.